Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sarangapani, R.
Right arrow Articles by Andersen, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sarangapani, R.
Right arrow Articles by Andersen, M. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 67, 159-172 (2002)
Copyright © 2002 by the Society of Toxicology


BIOTRANSFORMATION AND TOXICOKINETICS

Dose-Response Modeling of Cytochrome P450 Induction in Rats by Octamethylcyclotetrasiloxane

Ramesh Sarangapani*, Justin Teeguarden*, Kathleen P. Plotzke{dagger}, James M. McKim, Jr.{dagger} and Melvin E. Andersen{ddagger},1

* The K.S. Crump Group, ICF Consulting, P.O. Box 14348, Research Triangle Park, North Carolina 27709; {dagger} Toxicology, Health and Environmental Sciences, Dow Corning Corporation, Midland, Michigan 48686; and {ddagger} Department of Environmental Health, CETT/Foothills Campus, Colorado State University, Ft. Collins, Colorado 80523

Inhalation of octamethylcyclotetrasiloxane (D4) induces CYP2B1/2 protein and causes liver enlargement. We have developed a pharmacodynamic (PD) extension to a physiologically based pharmacokinetic (PBPK) model to characterize these dose-response behaviors. The PD model simulates interactions of D4 with a putative receptor, leading to increased production of cytochrome P450 2B1/2. Induction was modeled with a Hill equation with dissociation constant, Kd, and Hill coefficient, N. Both a 1- and a 5-compartment liver model were evaluated. The PBPK model provided excellent simulations of tissue D4 and hepatic CYP2B1/2 protein concentrations following 6 h/day, 5-day inhalation exposures to 0, 1, 7, 30, 70, 150, 300, 500, 700, or 900 ppm D4. Either the 1- or 5-compartment liver model could accurately simulate increases in CYP2B1/2 protein in the liver. With a 1-compartment liver, Kd and N were 0.67 µM (free liver concentration) and 1.9, respectively. The 5-compartment model used higher N-values (~ 4.0) and varied Kd between compartments. The fitted 5-compartment model parameters were Kd = 0.67 µM in the midzonal compartment with geometric differences in Kd between compartments of 2.9. On the basis of unbound (free) plasma concentrations, D4 appeared to be a higher potency inducer than phenobarbital (PB). Dose-response curves for increased liver weights had N |mS 1.0 and Kd |mS 3.4 µM, very different values from those for enzyme induction. Exposure concentration leading to a 0.1% increase in CYP2B1/2 protein predicted by the 1- and 5-compartment models were 2.1 ppm and 5.1 ppm, respectively. The 1- and 5-compartment liver models provided very similar fits to the whole liver induction data, excluding the lowest dose, but the 5-compartment liver model had the additional advantage of simultaneously describing the regional induction of CYP2B1/2.

Key Words: siloxane; pharmacodynamic; enzyme induction; inhalation; modeling.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
M. B. Reddy, I. D. Dobrev, D. A. McNett, J. M. Tobin, M. J. Utell, P. E. Morrow, J. Y. Domoradzki, K. P. Plotzke, and M. E. Andersen
Inhalation Dosimetry Modeling with Decamethylcyclopentasiloxane in Rats and Humans
Toxicol. Sci., October 1, 2008; 105(2): 275 - 285.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. B. Reddy, M. E. Andersen, P. E. Morrow, I. D. Dobrev, S. Varaprath, K. P. Plotzke, and M. J. Utell
Physiological Modeling of Inhalation Kinetics of Octamethylcyclotetrasiloxane in Humans during Rest and Exercise
Toxicol. Sci., March 1, 2003; 72(1): 3 - 18.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
R. Sarangapani, J. Teeguarden, M. E. Andersen, R. H. Reitz, and K. P. Plotzke
Route-Specific Differences in Distribution Characteristics of Octamethylcyclotetrasiloxane in Rats: Analysis Using PBPK Models
Toxicol. Sci., January 1, 2003; 71(1): 41 - 52.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.